Proton pump inhibitors and risk of gastric cancer: A population-based cohort study

被引：0
|
作者：
Abrahami, Devin [1 ]
McDonald, Emily G. [2 ]
Schnitzer, Mireille [3 ]
Barkun, Alan [4 ]
Suissa, Samy [5 ]
Azoulay, Laurent [6 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
[2] McGill Univ, Div Internal Med, Dept Med, Hlth Ctr, Montreal, PQ, Canada
[3] Univ Montreal, Fac Pharm, Montreal, PQ, Canada
[4] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[5] McGill Univ, Dept Epidemiol & Biostat, Fac Med, Montreal, PQ, Canada
[6] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：13 / 14
页数：2
相关论文
共 50 条
  • [21] Use of proton pump inhibitors and risk of rosacea: A nationwide population-based study
    Dai, Ying-Xiu
    Tai, Ying-Hsuan
    Chen, Chih-Chiang
    Chang, Yun-Ting
    Chen, Tzeng-Ji
    Chen, Mu-Hong
    [J]. JOURNAL OF DERMATOLOGY, 2020, 47 (10): : 1126 - 1130
  • [22] Proton pump inhibitors and the risk of acute kidney injury in cancer patients receiving immune checkpoint inhibitors: A Danish population-based cohort study
    Munch, Philip Vestergaard
    Norgaard, Mette
    Heide-Jorgensen, Uffe
    Jensen, Simon Kok
    Birn, Henrik
    Christiansen, Christian Fynbo
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (07) : 1164 - 1173
  • [23] Effectiveness of proton pump inhibitors in idiopathic pulmonary fibrosis: A population-based cohort study
    Tran, Tanja
    Assayag, Deborah
    Ernst, Pierre
    Suissa, Samy
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 104 - 105
  • [24] Effectiveness of Proton Pump Inhibitors in Idiopathic Pulmonary Fibrosis A Population-Based Cohort Study
    Tran, Tanja
    Assayag, Deborah
    Ernst, Pierre
    Suissa, Samy
    [J]. CHEST, 2021, 159 (02) : 673 - 682
  • [25] Association between proton pump inhibitors use and risk of hip fracture: A general population-based cohort study
    Wei, Jie
    Chan, Andrew T.
    Zeng, Chao
    Bai, Xiaochun
    Lu, Na
    Lei, Guanghua
    Zhang, Yuqing
    [J]. BONE, 2020, 139
  • [26] Maintenance proton pump inhibitor usage and risk of colorectal cancer: A population-based Swedish cohort study
    Liu, Q.
    Wang, X.
    Engstrand, L.
    Sadr-Azodi, O.
    Fall, K.
    Brusselaers, N.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S8 - S8
  • [27] Maintenance proton pump inhibitor usage and risk of colorectal cancer: A population-based Swedish cohort study
    Liu, Qing
    Wang, Xinchen
    Engstrand, Lars
    Sadr-Azodi, Omid
    Fall, Katja
    Brusselaers, Nele
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 77 - 78
  • [28] PROTON PUMP INHIBITORS AND THE RISK OF ACUTE KIDNEY INJURY IN PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS: A POPULATION-BASED COHORT STUDY
    Munch, Philip Vestergaard
    Norgaard, Mette
    Heide-Jorgensen, Uffe
    Jensen, Simon Kok
    Birn, Henrik
    Christiansen, Christian Fynbo
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1063 - I1063
  • [29] Long-term proton pump inhibitors and risk of gastric cancer after eradication of H. pylori: A population-based study
    Leung, W. K.
    Chan, E. W.
    Wong, A. Y.
    Chen, L.
    Wong, I. C.
    Cheung, K. S.
    [J]. HELICOBACTER, 2017, 22
  • [30] Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study
    Cheung, Ka Shing
    Chan, Esther W.
    Wong, Angel Y. S.
    Chen, Lijia
    Wong, Ian C. K.
    Leung, Wai Keung
    [J]. GUT, 2018, 67 (01) : 28 - 35
12345